Zevia Q3 Net Sales $44.2M (+13.6% YoY); Net Loss $9.2M; Resets FY2022 Revenue Guidance to $158-160M

Zevia PBC

2022-Q3 EPS reported -$0.73 revenue$127,815,000

Net sales $44.2M, up 13.6% YoY; unit volume +2.3% to 3.6M cases.
Gross margin 43.3%, up 90bp sequentially; net loss $9.2M ($0.17 EPS loss), improved from $49.8M loss YoY.
Adjusted EBITDA loss improved to $2.1M from $3.5M YoY; cash $49.2M, no debt.
FY2022 net sales guidance reduced to $158-160M (14.2-15.7% growth); Q4 outlook $30-32M.
Cites customer inventory pressures and macro environment as headwinds.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Zevia PBC reported third quarter ended September 30, 2022 results: revenue $44.2 million, net income $9.2 million, EPS $0.17 per diluted share. Guidance reaffirmed.

Period: third quarter ended September 30, 2022
Revenue: $44.2 million
Net income: $9.2 million
EPS: $0.17 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

plant-based ingredients, today reported results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights • Net sales increased 13.6% year over year to $44.2 million • Unit volume increased 2.3% year over year to 3.6 million equivalized cases • Gross profit margin of 43.3% (1) • Net loss was $9.2 million, including $6.8 million of non-cash

View on SEC.gov

59 earnings releases filed in the last 30 days. Browse all earnings releases →

Zevia PBC filing history →

Source: SEC EDGAR

accession 0000950170-22-024149

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.